Âé¶¹´«Ã½Ó³»­

Âé¶¹´«Ã½Ó³»­

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

A Case of VRK1 Mutation Associated with Microcephaly and Childhood-Onset Motor Neuron Disease
Neuromuscular and Clinical Neurophysiology (EMG)
P9 - Poster Session 9 (12:00 PM-1:00 PM)
1-002
This case report contributes to the growing knowledge of VRK1 mutations and associated pathologies.
Mutations in the VRK1 gene have been associated with several pathologies, including pontocerebellar hypoplasia, spinal muscular atrophy (SMA), and hereditary motor and sensory neuropathies. Multiple different phenotypic presentations of VRK1 gene mutations have been described and have been associated with different types of mutations. At this time, the full spectrum of pathologic phenotypes and their associations with various mutations of VRK1 is unclear.
Not applicable 
Not applicable

We present a case of a 31 year old microcephalic male with childhood onset motor and gait difficulties. His symptoms began at age 5 with frequent falls, and by age 8 (3 years after symptom onset), he was wheel-chair bound. His motor weakness has continued to progress throughout adulthood, affecting both upper and lower extremities symmetrically with loss of deep tendon reflexes. His exam shows no evidence of upper motor neuron involvement. He has also developed chronic respiratory failure secondary to restrictive lung disease. There was concern for SMA, and a hereditary motor neuropathy genetic panel was ordered, which showed a heterozygous mutation in VRK1: one known pathogenic variant (c.266G>A) and one variant of uncertain significance (c.961C>T).

As more patients are diagnosed with motor pathologies associated with VRK1 mutations, the collective data will help elucidate the full spectrum of phenotypes and which variants are clinically significant. 

Authors/Disclosures
Tiffany A. Brown, MD
PRESENTER
Dr. Brown has nothing to disclose.
Carlayne E. Jackson, MD, FÂé¶¹´«Ã½Ó³»­ (University of Texas Health Science Center at San Antonio) Dr. Jackson has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for Âé¶¹´«Ã½Ó³»­. The institution of Dr. Jackson has received research support from NIH. The institution of Dr. Jackson has received research support from Massachussetts General Hospital.